FDA Asks Judge to Delay E-Cigarette Deadline, Citing Virus
WASHINGTON — The Food and Drug Administration asked a federal judge to grant a 120-day delay for a deadline for e-cigarette manufacturers to submit applications to keep their products on the market.
Citing “the exceptional circumstances presented by the global coronavirus outbreak,” the agency proposed moving the deadline to Sept. 9, from May 12.
The existing deadline was the product of a legal agreement in federal court, after regulators, public-health groups and vaping companies fought over the timing for years.
The agency said its priorities hadn’t changed, but disruptions caused by the outbreak would make it difficult for companies to meet the deadline.
“FDA remains acutely aware of the recent surge in youth use of e-cigarettes and the public health imperative to ensure that these and other deemed new tobacco products undergo premarket review,” Mitch Zeller, the FDA’s Director of the Center for Tobacco Products, said in a letter to Judge Paul Grimm filed Monday.
The new coronavirus has closed laboratories in the U.S. and shuttered factories overseas, making it difficult for companies to complete their applications, Zeller said. Some of the FDA’s staff have also been pulled into the pandemic response.
Zeller said that as of March 25 he had received more than 15 letters and emails from the industry asking for a delay. Tobacco giant Altria Group Inc. last week sent a letter seeking an extension.
Tony Abboud, executive director of the Vapor Technology Association, called the move “a step in the right direction” but said it likely won’t go far enough. The trade group sent a letter to the FDA earlier this month requesting a 180-day extension for large manufacturers and a 270-day extension for small ones.
“Given that no one can predict the length and severity of the COVID-19 commercial shutdown, we hope that the FDA will revisit the appropriateness of a September 2020 deadline in the coming months,” he said in a statement.
FDA spokeswoman Alison Hunt said in a statement that the coronavirus is affecting all FDA-regulated industries, including tobacco manufacturers, causing the agency to request the change.
©2020 Bloomberg News
Distributed by Tribune Content Agency, LLC.
In The News
WASHINGTON - President Joe Biden’s first slate of judicial nominees is a marked departure from the mostly white and mostly male picks of the Trump years. In all, Biden named 11 individuals he’d like to see on the bench, 10 to serve either as Federal Circuit... Read More
WASHINGTON -- As Congress struggled Friday to find the fine line between protecting crime victims and suspects in pre-trial proceedings, federal prosecutors were trying to recover from an embarrassing blunder. In both cases, the federal government seeks to eliminate stumbling blocks to fair trials. At a... Read More
The Kansas Senate has confirmed two women to serve on the state's court of appeals, including the first woman of color to serve in that position. In doing so, the Senate took steps to assure itself neither woman would be an "activist" intent on "legislating" from... Read More
A ruling by Britain's top court last week that said Royal Dutch Shell oil company could be liable in English courts for pollution by its subsidiary in Nigeria, is likely to expand the company’s potential liability abroad. The court’s decision also creates a likelihood of liability... Read More
When Gwen Boyd-Willis was released from a Georgia women’s prison after a four-month sentence for fraudulently using an ATM card left in a machine, she faced new barriers to gaining employment and becoming a productive member of society. Candid with her mistakes, she wanted to make... Read More
CHICAGO — Even five decades later, former federal prosecutor Dick Schultz has a pretty good idea of when the legendary Chicago 7 trial started to go off the rails: during the testimony of the very first witness. That day in September 1969, U.S. District Judge Julius Hoffman halted the trial after he was informed... Read More